Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1993-10-12
1997-01-07
Burn, Brian M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514106, 514891, 424601, 424604, A61K 3166
Patent
active
055917305
ABSTRACT:
The present invention provides metal ion/bisphosphonate complexes that are useful for the treatment and diagnosis of urinary calculi. Preferred bisphosphonates include etidronate, pamidronate (APD), methylene diphosphonate (MDP), and imidodiphosphonate (IDP). The metal ion is preferably a quadrivalent metal ion such as Sn.sup.+4.
REFERENCES:
patent: 3683080 (1972-08-01), Francis
patent: 4134969 (1979-01-01), Schmidt-Dunker
patent: 5488041 (1996-01-01), Barbier et al.
Leskovar, P., et al., "A Direct Comparison of the Litholytic Capacity of Renacidin and Some New Calcium Oxalate and/or Phosphate Dissolving Irrigation Systems," Urolithiasis and Related Clinical Research, pp. 627-630 (1984).
Curreri, P. A., et al., "A Comparative Appraisal of Adsorption of Citrate on Whewellite Seed Crystals," J. of Crystal Growth, 53:209-214 (1981).
Robertson, W. G., et al., "Inhibitors of the Growth and Aggregation of Calcium Oxalate Crystals in vitro," Clinica Chimica Acta, 43:31-37 (1973).
Ohata, M., et al., "The effect of diphosphonate on calcium phosphate crystallization in urine in vitro," Kidney International, 4:401-406 (1973).
Fraser, D., et al., "The Influence of Disodium Ethane-1-Hydroxy-1,1-Diphosphonate (EHDP) on the Development of Experimentally Induced Urinary Stones in Rats," Clinical Science, 42:197-207 (1972).
Fleisch, H., "Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism," Recent Results in Cancer Research, 116:1-28 (1989).
Baumann, J. M., et al., "Biochemical and clinical effects of ethane-1-hydroxy-1,1-diphosphonate in calcium nephrolithiasis," Clinical Science and Molecular Medicine, 54:509-516 (1978).
Francis, M. D., et al., "Diphosphonates Inhibit Formation of Calcium Phosphate Crystals in vitro and Pathological Calcification in vivo," Science, 165:1264-1266 (19 Sep. 1969).
Barker, M. C. J., et al., "In-vivo labelling of renal calculi with technetium 99m methylene diphosphonate," British Journal of Radiology, 55:39-41 (1982).
Corcos, J., et al., "Radio-Contrast Enhancement of Urinary Tract Stones," J. of Urology, 145:618-623 (Mar. 1991).
Bone, H. E., III, et al., "Treatment of Calcium Urolithiasis with Diphosphonate Efficacy and Hazards," J. of Urology, 121:568-571 (1979).
Pak, C. Y. C., et al., "Effect of diphosphonate on crystallization of calcium oxalate in vitro," Kidney International, 7:154-160 (1975).
McCredie, D. A., et al., "Diphosphonate Therapy in Nephrocalcinosis," British Journal of Urology, 48:93-100 (1976).
Caniggia, A., et al., "Kinetics of .sup.99m Technetium-Tin-Methylene-Diphosphonate in Normal Subjects and Pathological Conditions: A Simple Index of Bone Metabolism," Calcif. Tissue Int., 30:5-13 (1980).
Stoller Marshall L.
Wolf, Jr. James S.
Burn Brian M.
The Regents of the University of California
LandOfFree
Inhibition of urinary calculi growth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of urinary calculi growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of urinary calculi growth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1764270